Benzodiazepine prescriptions for U.S. military veterans with PTSD declined due to decreased prevalence over a 10-year period, according to a retrospective observational study published in the Journal of Clinical Psychiatry.
“Given concerns about inappropriate prescribing in post-9/11 veterans, a particular emphasis for [the Veterans Health Administration] has centered on developing innovative strategies to deprescribe off-label medications,” Nancy C. Bernardy, PhD, of the department of psychiatry at Geisel School of Medicine at Dartmouth, and colleagues wrote.
Researchers sought to